Fluorescent marks for use in medical devices (Q11207): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement) |
(Changed an Item: Change because item Q214255 was merged with Q4859) |
||
| Property / contained in NUTS | Property / contained in NUTS | ||
Revision as of 16:06, 27 December 2020
Project Q11207 in Czech Republic
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fluorescent marks for use in medical devices |
Project Q11207 in Czech Republic |
Statements
4,208,983.49 Czech koruna
0 references
10,525,090.0 Czech koruna
0 references
39.99 percent
0 references
20 April 2017
0 references
18 April 2020
0 references
EXBIO Praha, a.s.
0 references
49°59'0.49"N, 14°30'9.11"E
0 references
25250
0 references
Projekt je zaměřen na VaV technologie přípravy specifických fluorescenčních značek, tzv. tandemových fluorochromů, která umožní výrobu skupiny produktů - In vitro diagnostických (IVD) zdravotnických prostředků pro identifikaci maligních, reaktivních a normálních krevních buněk v klinických vzorcích pomocí průtokové cytometrie. Splněním požadavků regulace 21 CFR 820 bude zaručena možnost registrace nových produktů pro klinické aplikace na celosvětových trzích, včetně USA. a. (Czech)
0 references
The project is focused on R & D technologies for the preparation of specific fluorescent brands, called tandem fluorochromes, which will enable the production of a group of products – In vitro diagnostic (IVD) medical devices for the identification of malignant, reactive and normal blood cells in clinical samples using flow cytometry. Compliance with the requirements of regulation 21 CFR 820 will guarantee the possibility of registration of new products for clinical applications in global markets, including USA. a. (English)
22 October 2020
0 references
Identifiers
CZ.01.1.02/0.0/0.0/16_083/0010233
0 references